Characterization of the defect in the Na+-Phosphate transporter in vitamin D-resistant hypophosphatemic mice

Nozomu Nakagawa, Noushin Arab, Fayez K Ghishan

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Hypophosphatemic vitamin D-resistant rickets is the most common form of vitamin D-resistant rickets in man. The hypophosphatemic mouse model (Hyp) is phenotypically and biochemically similar to the human disease. Biochemically, hypophosphatemia is the hallmark of this disorder. The cause of the hypophosphatemia is thought to be secondary to a defect in the renal and/or intestinal Na+-phosphate transporter. The current studies were designed to investigate and characterize the localization of the defect in the Na+-phosphate transporter in this disorder. Phosphate uptake by renal brush border membrane vesicles (BBMV) showed a significant decrease in the slope of the initial rate of phosphate uptake in (Hyp) compared with control mice (0.009 versus 0.013, respectively). The slopes representing initial rates of phosphate uptake by jejunal BBMV were similar in (Hyp) and control mice (0.004 and 0.004, respectively). Kinetics of jejunal Na+-dependent phosphate uptake showed a Vmax of 0.63 ± 0.12 and 0.64 ± 0.12 nmol/mg protein/15 s in (Hyp) and control mice, respectively, whereas Km values were 0.12 ± 0.08 and 0.2 ± 0.11 mM, respectively. Similar kinetic analysis in the kidney showed a Vmax of 0.32 ± 0.06 and 1.6 ± 0.1 (p < 0.01) and Km of 0.07 ± 0.06 and 0.39 ± 0.05 (p ̈ 0.02(Hyp) and control mice, respectively. Na+-dependent D-glucose uptake by BBMVs of intestine and kidney showed typical over-shoot phenomena in (Hyp) and control mice. In order to explore these findings further, Na+-phosphate transporter expression from intestine and kidney was accomplished by microinjection of 50 ng of poly(A)+ RNA into Xenopus laevis oocytes. Na+-dependent phosphate uptake was expressed 6 days after the microinjection of intestinal and kidney poly(A)+ RNA from control mice. However, expression of the transporter from (Hyp) mice occurred only from the intestine, and not from the kidney. The decrease in the expression of the Na+-dependent phosphate transporter was not secondary to accelerated efflux of phosphate or decreased metabolism in oocytes injected with poly(A)+ RNA from (Hyp) mice. α-Methyl-D-glucose was expressed equally from the kidneys of (Hyp) and control mice. The combined results of brush border membrane and X. laevis oocyte studies suggest that the cause of hypophosphatemia in (Hyp) mice is secondary to a defect in coding for the phosphate transporter, resulting in diminished activity and/or function of the Na+-dependent phosphate transporter in the kidney, but not in the intestine. Alternatively, the diminished expression could be secondary to a decrease in mRNA concentration for the Na+-phosphate co-transporter.

Original languageEnglish (US)
Pages (from-to)13616-13620
Number of pages5
JournalJournal of Biological Chemistry
Volume266
Issue number21
StatePublished - 1991
Externally publishedYes

Fingerprint

Phosphate Transport Proteins
Hypophosphatemia
Vitamin D
Phosphates
Defects
Kidney
Brushes
Messenger RNA
Intestines
Membranes
Microvilli
Hypophosphatemic Rickets
Oocytes
Symporters
Glucose
Xenopus laevis
Microinjections
Kinetics
Metabolism

ASJC Scopus subject areas

  • Biochemistry

Cite this

Characterization of the defect in the Na+-Phosphate transporter in vitamin D-resistant hypophosphatemic mice. / Nakagawa, Nozomu; Arab, Noushin; Ghishan, Fayez K.

In: Journal of Biological Chemistry, Vol. 266, No. 21, 1991, p. 13616-13620.

Research output: Contribution to journalArticle

@article{7ae24a371b974e0e987250513a32a063,
title = "Characterization of the defect in the Na+-Phosphate transporter in vitamin D-resistant hypophosphatemic mice",
abstract = "Hypophosphatemic vitamin D-resistant rickets is the most common form of vitamin D-resistant rickets in man. The hypophosphatemic mouse model (Hyp) is phenotypically and biochemically similar to the human disease. Biochemically, hypophosphatemia is the hallmark of this disorder. The cause of the hypophosphatemia is thought to be secondary to a defect in the renal and/or intestinal Na+-phosphate transporter. The current studies were designed to investigate and characterize the localization of the defect in the Na+-phosphate transporter in this disorder. Phosphate uptake by renal brush border membrane vesicles (BBMV) showed a significant decrease in the slope of the initial rate of phosphate uptake in (Hyp) compared with control mice (0.009 versus 0.013, respectively). The slopes representing initial rates of phosphate uptake by jejunal BBMV were similar in (Hyp) and control mice (0.004 and 0.004, respectively). Kinetics of jejunal Na+-dependent phosphate uptake showed a Vmax of 0.63 ± 0.12 and 0.64 ± 0.12 nmol/mg protein/15 s in (Hyp) and control mice, respectively, whereas Km values were 0.12 ± 0.08 and 0.2 ± 0.11 mM, respectively. Similar kinetic analysis in the kidney showed a Vmax of 0.32 ± 0.06 and 1.6 ± 0.1 (p < 0.01) and Km of 0.07 ± 0.06 and 0.39 ± 0.05 (p ̈ 0.02(Hyp) and control mice, respectively. Na+-dependent D-glucose uptake by BBMVs of intestine and kidney showed typical over-shoot phenomena in (Hyp) and control mice. In order to explore these findings further, Na+-phosphate transporter expression from intestine and kidney was accomplished by microinjection of 50 ng of poly(A)+ RNA into Xenopus laevis oocytes. Na+-dependent phosphate uptake was expressed 6 days after the microinjection of intestinal and kidney poly(A)+ RNA from control mice. However, expression of the transporter from (Hyp) mice occurred only from the intestine, and not from the kidney. The decrease in the expression of the Na+-dependent phosphate transporter was not secondary to accelerated efflux of phosphate or decreased metabolism in oocytes injected with poly(A)+ RNA from (Hyp) mice. α-Methyl-D-glucose was expressed equally from the kidneys of (Hyp) and control mice. The combined results of brush border membrane and X. laevis oocyte studies suggest that the cause of hypophosphatemia in (Hyp) mice is secondary to a defect in coding for the phosphate transporter, resulting in diminished activity and/or function of the Na+-dependent phosphate transporter in the kidney, but not in the intestine. Alternatively, the diminished expression could be secondary to a decrease in mRNA concentration for the Na+-phosphate co-transporter.",
author = "Nozomu Nakagawa and Noushin Arab and Ghishan, {Fayez K}",
year = "1991",
language = "English (US)",
volume = "266",
pages = "13616--13620",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

TY - JOUR

T1 - Characterization of the defect in the Na+-Phosphate transporter in vitamin D-resistant hypophosphatemic mice

AU - Nakagawa, Nozomu

AU - Arab, Noushin

AU - Ghishan, Fayez K

PY - 1991

Y1 - 1991

N2 - Hypophosphatemic vitamin D-resistant rickets is the most common form of vitamin D-resistant rickets in man. The hypophosphatemic mouse model (Hyp) is phenotypically and biochemically similar to the human disease. Biochemically, hypophosphatemia is the hallmark of this disorder. The cause of the hypophosphatemia is thought to be secondary to a defect in the renal and/or intestinal Na+-phosphate transporter. The current studies were designed to investigate and characterize the localization of the defect in the Na+-phosphate transporter in this disorder. Phosphate uptake by renal brush border membrane vesicles (BBMV) showed a significant decrease in the slope of the initial rate of phosphate uptake in (Hyp) compared with control mice (0.009 versus 0.013, respectively). The slopes representing initial rates of phosphate uptake by jejunal BBMV were similar in (Hyp) and control mice (0.004 and 0.004, respectively). Kinetics of jejunal Na+-dependent phosphate uptake showed a Vmax of 0.63 ± 0.12 and 0.64 ± 0.12 nmol/mg protein/15 s in (Hyp) and control mice, respectively, whereas Km values were 0.12 ± 0.08 and 0.2 ± 0.11 mM, respectively. Similar kinetic analysis in the kidney showed a Vmax of 0.32 ± 0.06 and 1.6 ± 0.1 (p < 0.01) and Km of 0.07 ± 0.06 and 0.39 ± 0.05 (p ̈ 0.02(Hyp) and control mice, respectively. Na+-dependent D-glucose uptake by BBMVs of intestine and kidney showed typical over-shoot phenomena in (Hyp) and control mice. In order to explore these findings further, Na+-phosphate transporter expression from intestine and kidney was accomplished by microinjection of 50 ng of poly(A)+ RNA into Xenopus laevis oocytes. Na+-dependent phosphate uptake was expressed 6 days after the microinjection of intestinal and kidney poly(A)+ RNA from control mice. However, expression of the transporter from (Hyp) mice occurred only from the intestine, and not from the kidney. The decrease in the expression of the Na+-dependent phosphate transporter was not secondary to accelerated efflux of phosphate or decreased metabolism in oocytes injected with poly(A)+ RNA from (Hyp) mice. α-Methyl-D-glucose was expressed equally from the kidneys of (Hyp) and control mice. The combined results of brush border membrane and X. laevis oocyte studies suggest that the cause of hypophosphatemia in (Hyp) mice is secondary to a defect in coding for the phosphate transporter, resulting in diminished activity and/or function of the Na+-dependent phosphate transporter in the kidney, but not in the intestine. Alternatively, the diminished expression could be secondary to a decrease in mRNA concentration for the Na+-phosphate co-transporter.

AB - Hypophosphatemic vitamin D-resistant rickets is the most common form of vitamin D-resistant rickets in man. The hypophosphatemic mouse model (Hyp) is phenotypically and biochemically similar to the human disease. Biochemically, hypophosphatemia is the hallmark of this disorder. The cause of the hypophosphatemia is thought to be secondary to a defect in the renal and/or intestinal Na+-phosphate transporter. The current studies were designed to investigate and characterize the localization of the defect in the Na+-phosphate transporter in this disorder. Phosphate uptake by renal brush border membrane vesicles (BBMV) showed a significant decrease in the slope of the initial rate of phosphate uptake in (Hyp) compared with control mice (0.009 versus 0.013, respectively). The slopes representing initial rates of phosphate uptake by jejunal BBMV were similar in (Hyp) and control mice (0.004 and 0.004, respectively). Kinetics of jejunal Na+-dependent phosphate uptake showed a Vmax of 0.63 ± 0.12 and 0.64 ± 0.12 nmol/mg protein/15 s in (Hyp) and control mice, respectively, whereas Km values were 0.12 ± 0.08 and 0.2 ± 0.11 mM, respectively. Similar kinetic analysis in the kidney showed a Vmax of 0.32 ± 0.06 and 1.6 ± 0.1 (p < 0.01) and Km of 0.07 ± 0.06 and 0.39 ± 0.05 (p ̈ 0.02(Hyp) and control mice, respectively. Na+-dependent D-glucose uptake by BBMVs of intestine and kidney showed typical over-shoot phenomena in (Hyp) and control mice. In order to explore these findings further, Na+-phosphate transporter expression from intestine and kidney was accomplished by microinjection of 50 ng of poly(A)+ RNA into Xenopus laevis oocytes. Na+-dependent phosphate uptake was expressed 6 days after the microinjection of intestinal and kidney poly(A)+ RNA from control mice. However, expression of the transporter from (Hyp) mice occurred only from the intestine, and not from the kidney. The decrease in the expression of the Na+-dependent phosphate transporter was not secondary to accelerated efflux of phosphate or decreased metabolism in oocytes injected with poly(A)+ RNA from (Hyp) mice. α-Methyl-D-glucose was expressed equally from the kidneys of (Hyp) and control mice. The combined results of brush border membrane and X. laevis oocyte studies suggest that the cause of hypophosphatemia in (Hyp) mice is secondary to a defect in coding for the phosphate transporter, resulting in diminished activity and/or function of the Na+-dependent phosphate transporter in the kidney, but not in the intestine. Alternatively, the diminished expression could be secondary to a decrease in mRNA concentration for the Na+-phosphate co-transporter.

UR - http://www.scopus.com/inward/record.url?scp=0025770061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025770061&partnerID=8YFLogxK

M3 - Article

C2 - 1649826

AN - SCOPUS:0025770061

VL - 266

SP - 13616

EP - 13620

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -